Connect with us
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The two companies also plan to restructure...
Effectively ending their self-imposed halt this year, drugmakers will start the new year with drug price increases.
Meanwhile, Shionogi & Co.'s Xofluza drug, which can kill the flu virus within 24 hours, has received the approval of the Japanese health ministry.